Trellus Management Company, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Trellus Management Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$64.07 - $91.75 $615,071 - $880,800	-9,600 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$65.07 - $98.24 $624,671 - $943,104	9,600 New	9,600 $823,000
Q2 2020 Aug 12, 2020	SELL	$29.01 - $74.23 $725,250 - $1.86 Million	-25,000 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$27.51 - $57.29 $412,650 - $859,350	15,000 Added 150.0%	25,000 $851,000
Q4 2019 Feb 20, 2020	BUY	$40.86 - $57.65 $85,806 - $121,065	2,100 Added 26.58%	10,000 $544,000
Q3 2019 Nov 01, 2019	BUY	$37.38 - $49.47 $52,332 - $69,258	1,400 Added 21.54%	7,900 $330,000
Q2 2019 Jul 31, 2019	BUY	$39.79 - $67.01 $258,635 - $435,565	6,500 New	6,500 $285,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.